메뉴 건너뛰기




Volumn 13, Issue 19, 2007, Pages 2768-2769

Fecal tumor M2 pyruvate kinase is not a specific biomaker for colorectal cancer screening

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN M2; PYRUVATE KINASE;

EID: 34250750124     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i19.2768     Document Type: Letter
Times cited : (5)

References (7)
  • 1
    • 33751513942 scopus 로고    scopus 로고
    • Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
    • Tonus C, Neupert G, Sellinger M. Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK. World J Gastroenterol 2006; 12: 7007-7011
    • (2006) World J Gastroenterol , vol.12 , pp. 7007-7011
    • Tonus, C.1    Neupert, G.2    Sellinger, M.3
  • 2
    • 33750626736 scopus 로고    scopus 로고
    • Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal. neoplasia
    • Shastri YM, Naumann M, Oremek GM, Hanisch E, Rosch W, Mossner J, Caspary WF, Stein JM. Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal. neoplasia. Int J Cancer 2006; 119: 2651-2656
    • (2006) Int J Cancer , vol.119 , pp. 2651-2656
    • Shastri, Y.M.1    Naumann, M.2    Oremek, G.M.3    Hanisch, E.4    Rosch, W.5    Mossner, J.6    Caspary, W.F.7    Stein, J.M.8
  • 4
    • 0037629022 scopus 로고    scopus 로고
    • Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls
    • Hardt PD, Toepler M, Ngoumou B, Rupp J, Kloer HU. Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls. Anticancer Res 2003; 23:851-853
    • (2003) Anticancer Res , vol.23 , pp. 851-853
    • Hardt, P.D.1    Toepler, M.2    Ngoumou, B.3    Rupp, J.4    Kloer, H.U.5
  • 6
    • 4444281174 scopus 로고    scopus 로고
    • Faecal pyruvate kinase type M2 - a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study
    • Naumann M, Schaum B, Oremek GM, Hanisch E, Rosch W, Mossner J, Caspary WF, Stein J. Faecal pyruvate kinase type M2 - a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study. Dtsch Med Wochenschr 2004; 129:1806-1807
    • (2004) Dtsch Med Wochenschr , vol.129 , pp. 1806-1807
    • Naumann, M.1    Schaum, B.2    Oremek, G.M.3    Hanisch, E.4    Rosch, W.5    Mossner, J.6    Caspary, W.F.7    Stein, J.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.